Greenwich LifeSciences, Inc.
GLSI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001799788
In the last 90 days, Greenwich LifeSciences, Inc. insiders filed 3 open-market purchases and 0 sales; 57 institutions reported holding it in 13F filings for Q2 2026, worth $39.6M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Greenwich LifeSciences, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +1 vs. Q1 2022
- Shares held
- 1.03M
- +101.7K (+10.9%) vs. Q1 2022
- Total value
- $8.74M
- −$9.53M (−52.2%) vs. Q1 2022
- New holders
- 14
- 7 more added
- Sold out
- 13
- 10 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GLSI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 57 | $39.6M |
| Q1 2026 | 64 | $41.1M |
| Q4 2025 | 50 | $27.9M |
| Q3 2025 | 51 | $12.1M |
| Q2 2025 | 51 | $11.2M |
| Q1 2025 | 46 | $11.1M |
| Q4 2024 | 42 | $13.3M |
| Q3 2024 | 39 | $16.4M |
| Q2 2024 | 34 | $17.7M |
| Q1 2024 | 31 | $13.2M |
| Q4 2023 | 27 | $5.70M |
| Q3 2023 | 24 | $4.75M |
| Q2 2023 | 23 | $6.06M |
| Q1 2023 | 28 | $11.4M |
| Q4 2022 | 22 | $10.2M |
| Q3 2022 | 21 | $7.21M |
| Q2 2022 | 34 | $8.74M |
| Q1 2022 | 34 | $18.3M |
| Q4 2021 | 35 | $19.4M |
| Q3 2021 | 36 | $31.9M |
| Q2 2021 | 30 | $36.4M |
| Q1 2021 | 19 | $8.90M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Greenwich LifeSciences, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 354,236 | $3.00M | 0.00% | −20,964−5.6% | Reduced |
| Renaissance Technologies LLC | 105,159 | $891.0K | 0.00% | +105,159 | New |
| Millennium Management LLC | 90,292 | $765.0K | 0.00% | +90,292 | New |
| Marshall Wace, LLP | 89,736 | $760.0K | 0.00% | +68,831+329.3% | Added |
| Morgan Stanley | 73,190 | $619.0K | 0.00% | +51,483+237.2% | Added |
| BlackRock Inc. | 51,051 | $433.0K | 0.00% | −185,204−78.4% | Reduced |
| Ameriprise Financial Inc | 42,181 | $359.0K | 0.00% | −526−1.2% | Reduced |
| Geode Capital Management, LLC | 40,979 | $347.0K | 0.00% | −28,733−41.2% | Reduced |
| Occudo Quantitative Strategies LP | 23,440 | $199.0K | 0.02% | +23,440 | New |
| Two Sigma Investments, LP | 21,431 | $182.0K | 0.00% | +21,431 | New |
| Ergoteles LLC | 20,000 | $169.0K | 0.01% | +20,000 | New |
| Schonfeld Strategic Advisors LLC | 17,800 | $151.0K | 0.00% | +17,800 | New |
| Citadel Advisors LLC | 17,657 | $150.0K | 0.00% | +17,657 | New |
| D. E. Shaw & Co., Inc. | 17,631 | $149.0K | 0.00% | +17,631 | New |
| Cubist Systematic Strategies, LLC | 15,332 | $130.0K | 0.00% | +15,332 | New |
| State Street Corp | 13,002 | $110.0K | 0.00% | −53,483−80.4% | Reduced |
| Goldman Sachs Group Inc | 12,322 | $104.0K | 0.00% | +12,322 | New |
| Bank of America Corp | 10,645 | $90.0K | 0.00% | +4,432+71.3% | Added |
| Walleye Capital LLC | 10,656 | $90.0K | 0.00% | +10,656 | New |
| Royal Bank of Canada | 1,400 | $12.0K | 0.00% | −252−15.3% | Reduced |
| Tower Research Capital LLC (TRC) | 1,291 | $11.0K | 0.00% | +796+160.8% | Added |
| Founders Capital Management | 1,000 | $8.00K | 0.01% | +1,000 | New |
| UBS Group AG | 870 | $7.00K | 0.00% | +45+5.5% | Added |
| Newbridge Financial Services Group, Inc. | 500 | $4.00K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 141 | $1.00K | 0.00% | +30+27.0% | Added |
| New York State Common Retirement Fund | 34 | $0 | 0.00% | −3,500−99.0% | Reduced |
| JPMorgan Chase & Co | 4 | $0 | 0.00% | −1,918−99.8% | Reduced |
| Wells Fargo & Company | 27 | $0 | 0.00% | −894−97.1% | Reduced |
| Citigroup Inc | 34 | $0 | 0.00% | −115−77.2% | Reduced |
| North Star Investment Management Corp. | 51 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Ellevest, Inc. | 24 | $0 | 0.00% | +16+200.0% | Added |
| Credit Suisse AG | 2 | $0 | 0.00% | +2 | New |
| Captrust Financial Advisors | 19 | $0 | 0.00% | +19 | New |
| Northern Trust Corp | 0 | $0 | 0.00% | −35,060−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −9,575−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −10,191−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −10,114−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −7,200−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −2,192−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −2,030−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −1,781−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −900−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −665−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −667−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −427−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −316−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |